<DOC>
	<DOCNO>NCT00168779</DOCNO>
	<brief_summary>The primary objective study compare effectiveness telmisartan 80 mg / hydrochlorothiazide 25 mg [ Micardis HCT ] valsartan 160 mg / hydrochlorothiazide 25 mg [ Diovan HCT ] placebo treatment Stage 1 Stage 2 hypertension .</brief_summary>
	<brief_title>Randomized , Double-Blind , Placebo-Controlled , Forced-Titration , Comparing Telmisartan v Valsartan . Taken Orally Eight Weeks Patients With Stage 1 Stage 2 Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>1 . Ability provide write informed consent . 2 . Age 18 year old 3 . Ability stop current antihypertensive therapy without unacceptable risk patient ( investigator 's discretion ) 4 . Seated cuff DBP ? 95 mmHg Visit 2 ( baseline ) 1 . Premenopausal woman ( last menstruation ? 1 year prior start runin period ) : 1. surgically sterile and/or 2. nursing pregnant 3. childbearing potential NOT practice acceptable mean birth control , NOT plan continue use method throughout study NOT agree submit periodic pregnancy test participation study &gt; 3months duration . Acceptable method birth control include oral , implantable , transdermal , injectable contraceptive , IntraUterine Device ( IUD ) . 2 . Known suspected secondary hypertension . 3 . Mean seat SBP &gt; = 180 mmHg mean seat DBP &gt; = 120 mmHg clinic visit prior randomization . 4 . Hepatic and/or renal dysfunction define follow laboratory parameter : 1 . SGPT ( ALT ) SGOT ( AST ) &gt; 2 time upper limit normal range , 2 . Serum creatinine &gt; 3.0 mg/dL creatinine clearance &lt; 0.6 ml/sec . 5 . Bilateral renal artery stenosis , renal artery stenosis solitary kidney , postrenal transplant one kidney . 6 . Clinically relevant hypokalemia hyperkalemia . 7 . Uncorrected volume depletion . 8 . Uncorrected sodium depletion . 9 . Primary aldosteronism . 10 . Hereditary fructose intolerance . 11 . Biliary obstructive disorder , cholestatis moderate severe hepatic sufficiency . 12 . Patients previously experience symptom characteristic angioedema treatment ACE inhibitor angiotensin II receptor antagonist . 13 . History drug alcohol dependency within six month prior start runin period . 14 . Chronic administration medication know affect blood pressure , exc</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>